DNAnexus, a pioneer in cloud-based genome informatics and data management, and Tute Genomics, a leading genome annotation and interpretation platform, have announced an integrated solution for genomic data management. Customers will be able to access the Tute platform and DNAnexus pipelines from either company’s cloud environment. DNAnexus provides an enterprise-level solution that combines cloud computing […]
23andMe appoint new Chief Science Officer and Head of Therapeutics.
Trovagene, Inc., a developer of cell-free molecular diagnostics, announced today that Matthew L. Posard has joined the Company as executive vice president and chief commercial officer. Posard (pictured) has more than 20 years of experience identifying, directing and successfully commercialising innovative technologies in the molecular diagnostic and life science fields. Most recently, he led the […]
Ohio-headquartered bioinformatics company, GenomeNext, LLC, a leader in genomic data management and integrated analysis, announced today that, through the “Intel Heads In The Clouds Challenge on Amazon Web Services (AWS)” with support from JHC Technology, and in conjunction with Nationwide Children’s Hospital, has benchmarked whole genome sequencing analysis at an unprecedented 1,000 genomes per day. […]
Researchers identified two regions of the genome associated with rosacea, an inflammatory and poorly understood skin disease. The regions may be linked to other systemic diseases.
UK Department of Health announce first genomic success stories.
New University of Michigan study adds to the growing body of evidence that patients welcome WGS.
A new study has uncovered 15 new breast cancer risk loci.
Genome-scale study points to drivers of tumor evolution and metastasis, provides roadmap for future in vivo Cas9 screens
NIH-supported Roadmap Epigenomics Program have successfully mapped the epigenomes of more than 100 cell types.
New collaboration between Foundation Medicine and H3 aims to develop precision cancer therapies.
23andMe and FDA make significant progress in direct-to-consumer testing.
Anti-cancer cell therapies and the end of the CRISPR-Cas9 controversy.
Tel Aviv University researcher identifies novel genetic mutations through DNA sequencing of afflicted child and family.
A new UK based project, seeks to improve understanding of blood cancer genomics for improved treatment.